Literature DB >> 7239706

Pharmacokinetic analysis and calculations using a program for the minicalculator TI-59.

F Nielsen-Kudsk.   

Abstract

The described pharmacokinetic program for TI-59 is in clinical practice applicable in analyses of plasma concentration profiles established after single-dose, intravenous or oral administration of drugs showing one- or two-compartment first-order pharmacokinetics. Analysis of multiple dose, steady state plasma concentration data may also be carried out. Predictions of mean steady state plasma concentrations related to multiple dose drug administration are obtainable on the basis of a preceding single-dose pharmacokinetic analysis. The program contains routines for: exponential regression analysis, determination of and treatment of residuals, simulation of plasma concentration curves, corrections for time-defined intravenous infusion substituting for bolus injection, determination of and correction for lag-time and routines for calculation of fitted and derived pharmacokinetic parameters. Naproxen and theophylline plasma concentration data were used to demonstrate the practical applications of the program.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7239706     DOI: 10.1016/0020-7101(81)90028-3

Source DB:  PubMed          Journal:  Int J Biomed Comput        ISSN: 0020-7101


  5 in total

1.  Simulation of human serum pharmacokinetics of ticarcillin-clavulanic acid and ceftazidime in rabbits, and efficacy against experimental Klebsiella pneumoniae meningitis.

Authors:  L Mizen; G Woodnutt; I Kernutt; E J Catherall
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

2.  Absorption of iohexol from cerebrospinal fluid to blood: pharmacokinetics in humans.

Authors:  B Olsson; O P Eldevik; T A Grønnerød
Journal:  Neuroradiology       Date:  1985       Impact factor: 2.804

3.  Pharmacokinetics and distribution of ticarcillin-clavulanic acid (Timentin) in experimental animals.

Authors:  G Woodnutt; I Kernutt; L Mizen
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

4.  Simulation of human serum pharmacokinetics of cefazolin, piperacillin, and BRL 42715 in rats and efficacy against experimental intraperitoneal infections.

Authors:  G Woodnutt; V Berry; L Mizen
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

5.  Temocillin efficacy in experimental Klebsiella pneumoniae meningitis after infusion into rabbit plasma to simulate antibiotic concentrations in human serum.

Authors:  G Woodnutt; E J Catherall; I Kernutt; L Mizen
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.